KRAS and non-small cell lung carcinoma: For this reason, the main aims of the study were estimation of the incidence of the most common KRAS mutations in codons 12, 13 and 61 and BRAF V600E substitution in the central nervous system (CNS) metastases in Caucasian patients with advanced NSCLC.